Skip to content
Stop using now Drug recall · FDA · Published March 16, 2020

PharMEDium Recalls Succinylcholine Chloride IV Syringes Due to Sterility Issues

PharMEDium Services recalls 46 lots of succinylcholine chloride IV syringes due to lack of sterility assurance. Check lot numbers and distribution details.

🇺🇸 FDA recall #D-1086-2020DrugPharMEDium ›
Take action

Contact the company

Recalling firmPharMEDium Services, LLC36 Stults Rd · Dayton, NJ 08810
✎ GovInfoNow plain-language explainer

What happened, in plain English

PharMEDium Services, LLC is recalling 46 lots of succinylcholine chloride in 5 mL BD syringes because the products lack sterility assurance. The affected units were distributed nationwide in the US. This recall involves Class II classification, indicating a potential for serious adverse health consequences if used. Read more at govinfonow.com/recall/37308-pharmedium-recalls-succinylcholine-chloride-iv-syringes-due-to-sterility-issues.

Source Summary by GovInfoNow · govinfonow.com/recall/37308-pharmedium-recalls-succinylcholine-chloride-iv-syringes-due-to-sterility-issues · Updated October 11, 2026 · FDA enforcement record: FDA #D-1086-2020

Cite this page

“PharMEDium Recalls Succinylcholine Chloride IV Syringes Due to Sterility Issues.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/37308-pharmedium-recalls-succinylcholine-chloride-iv-syringes-due-to-sterility-issues. Based on FDA recall #D-1086-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1086-2020%22&limit=1).

Why it’s dangerous

The lack of sterility assurance means the syringes may contain harmful microorganisms. Using a non-sterile injectable medication can lead to serious infections or other adverse health consequences in patients.

Who’s affected

Healthcare providers and facilities that have received or are using succinylcholine chloride IV syringes from PharMEDium Services. Patients receiving intravenous administration of this specific drug are at risk of exposure to non-sterile product.

How to tell if you have this one

Look for succinylcholine Chloride, 20 mg per 5 mL or 100 mg per 5 mL, in 5 mL BD Syringes intended for IV Use. Check the NDC number 71019-341-04 and lot numbers such as 193500014D (expiration 3/16/2020) and 193510018D (expiration 3/17/2020). The manufacturer address is 913 N. Davis Ave, Cleveland, MS.

  • Brand
    PharMEDium
  • Category
    Drug
FDA recall event · 13 products

All 13 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Distributed Nationwide in the US
Recall numberProduct, codes & lotsQuantity
D-1081-2020ePHEDrine Sulfate, 5 mg per mL, 50 mg per 10 mL, In 0.9% Sodium Chloride 10 mL syringe, For IV Use Preservative Free PharMEDium 913 N. Davis Ave. Cleveland, MS NDC 71030-003-12; 193500004D 3/16/2020 193510006D 3/17/2020 193530011D 3/19/2020 193570003D 3/23/20201075 units
D-1082-2020nICARdipine HCl (0.1 mg/mL) 1 mg/10mL, in 0.9% Sodium Chloride Injection USP, 10 ml in a 20mL syringe, Rx Only, PharMEDium Services LLC 12620 W. Airport Boulevard #130 Sugar Land, TX 77470. NDC 71019-206-01; 193540006D, Exp 3/22/202080 units
D-1083-2020rocuronium Bromide 10 mg per mL 50 mg per 5 mL, 5 mL BD Syringe, For IV Use, PharMEDium 913 N. Davis Ave. Cleveland, MS. Preservative Free, NDC 71019-321-10; 193510017D 3/17/2020 193530001D 3/19/2020 193540002D 3/22/20204625 units
D-1084-2020HYDROmorphone in 0.9% Sodium Chloride HCl, 1 mg per mL, For IV Use, 30 mg per 30 mL, 30 mL in a 35 mL Monoject Barrel Syringe, PharMEDium Services LLC 913 M. Davis Ave Cleveland, MS. NDC 61553-166-44; 193510022D 3/17/2020 193510023D 3/17/2020 193580012D 3/25/2020 193600013D 3/26/2020 193640016D 3/30/2020 193530020D 3/19/2020 193540023D 3/22/2020 193540026D 3/22/20201840 units
D-1085-2020fentaNYL Citrate 10 mcg per mL, 2,500 mcg per 250 mL, 250 mL in a LifeCare Bag, in Sodium Chloride 0.9%. Rx Only, PharMEDium Services, LLC 913 N. Davis Ave Cleveland, MS 36732 NDC 61553-113-50; 193610002D, Exp 3/29/2020210 units
D-1086-2020succinylcholine Chloride, 20 mg per 5 mL, 100 mg per 5 mL, 5 mL BD Syringe, For IV Use, PharMEDium 913 N. Davis Ave, Cleveland, MS. NDC 71019-341-04; 193500014D 3/16/2020 193510018D 3/17/20202475 units
D-1087-2020rocuronium Bromide, 10 mg per mL, 50 mg per 5 mL, 5 mL BD Syringe, for IV Use, PharMEDium 13N. Davis Ave. Cleveland MS 36732. NDC 71019-321-05; 193500019D 3/16/2020 193510014D 3/17/2020 193520009D 3/18/20202250 units
D-1088-2020ePHEDrine Sulfate, 5 mg per mL, 25 mg per 5 mL in 0.9% Sodium Chloride, 5 mL syringe, For IV use, Preservative Free, PharMEDium 913 W Davis Ave Cleveland MS 38732 NDC 71030-003-09; 193500012D, Exp 3/16/2020375 units
D-1089-2020fentaNYL Citrate 50 mcg per mL, (Preservative Free) Injection, For IV use, 1,500 mcg per 30 mL, 30 mL Total Volume, in a 35 mL Monoject Barrel Syringe, PharMEDium Services, LLC 913 N. Davis Avenue Cleveland, MS 38732. NDC 61553-672-44; 193510008D 3/17/2020 193580004D 3/25/020290 units
D-1090-2020ePHEDrine Sulfate 5 mg per mL 25 mg per 5 mL, in 0.9% Sodium Chloride, 5 mL BD Syringe, For IV Use, Rx Only, PharMEDium 913 N. Davis Ave. Cleveland, MS 98732 NDC 71030-003-02; 193510031D, Exp 3/17/20201500 units
D-1091-2020ePHEDrine Sulfate 10 mg per mL 50 mg per 5 mL in 0.9% 5 mL Sodium Chloride 5 mL syringe, For IV Use, Rx Only, PharMEDium 913 N Davis Avenue Cleveland, MS NDC 71030-001-09; 193520006D 3/18/2020 193530009D 3/19/2020900 units
D-1092-2020fentaNYL Citrate Injection, 50 mcg per mL, 250 mcg per 5 mL 5 mL syringe, For IV Use, Rx Only, PharMEDium Services, LLC 36 Stutte Road Dayton, NJ. NDC 61553-306-33; 193530007D, Exp 3/19/202075 units
D-1093-2020fentaNYL Citrate Injection 50 mcg per mL, 100 mcg per 2 mL, 2 mL per syringe, For IV Use, Rx Only, PharMEDium Services, LLC 913 N. Davis Ave Cleveland, MS 05810. NDC 61553-303-28; 193520008D, Exp 3/18/2020 193540005D, Exp 3/22/20201350 units
Based on the official FDA remedy

What to do — step by step

  1. Stop using the product

    Do not use any succinylcholine chloride IV syringes from the recalled lots due to sterility concerns.

  2. Identify affected lots

    Check your inventory for NDC 71019-341-04 and lot numbers including 193500014D and 193510018D.

  3. Contact manufacturer

    Reach out to PharMEDium Services, LLC for further instructions on return or disposal since the remedy is not explicitly stated in this record.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Distributed Nationwide in the US” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 4.9 years after the firm started it.

1. Firm started the recall: Mar 16, 202012. FDA classified it Class II: Apr 6, 202023. Published in FDA’s Enforcement Report: Apr 15, 202034. FDA terminated the recall: Feb 14, 2025420202025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Which lot numbers are affected?

46 lots are involved, including those with expiration dates like 3/16/2020 and 3/17/2020 associated with NDC 71019-341-04.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1086-2020 (March 16, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1086-2020 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA